Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Akouos

Akouos is a precision genetic medicine company developing gene therapies that restore and preserve hearing. Leveraging its adeno-associated viral vectors (AAV)-based gene therapy platform, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss. Headquartered in Boston, the Company was founded in 2016 by world leaders in the fields of neurotology, genetics, inner ear drug delivery and AAV gene therapy. Akouos has strategic partnerships with Massachusetts Eye and Ear Infirmary and Lonza, Inc.

Key Contact
Name
Manny Simons, Ph.D.
Title
CEO & Founder
Funding Events

Date
Amount
Type
Investors
Valuation
08/07/18 $50,000,000 Series A 5AM Ventures
New Enterprise Associates
Novartis Venture Funds
Partners Innovation Fund
RA Capital Management
Sofinnova Ventures
undisclosed


Featured Reading